Vaccinia-related kinase 2 variants differentially affect breast cancer growth by regulating kinase activity.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 421, doi. 10.32604/or.2023.031031
- By:
- Publication type:
- Article
Works matching IS 09650407 AND DT 2024 AND VI 32 AND IP 2
Results: 15
1
2
Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 393, doi. 10.32604/or.2023.031134
- By:
- Publication type:
- Article
3
Extensive prediction of drug response in mutation-subtype-specific LUAD with machine learning approach.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 409, doi. 10.32604/or.2023.042863
- By:
- Publication type:
- Article
4
TGF-β-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 373, doi. 10.32604/or.2023.031404
- By:
- Publication type:
- Article
5
GIPC1 promotes tumor growth and migration in gastric cancer via activating PDGFR/PI3K/AKT signaling.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 361, doi. 10.32604/or.2023.043807
- By:
- Publication type:
- Article
6
Absent in melanoma 2 attenuates proliferation and migration and promotes apoptosis of human colorectal cancer cells by activating P38MAPK signaling pathway.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 353, doi. 10.32604/or.2023.042986
- By:
- Publication type:
- Article
7
Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 339, doi. 10.32604/or.2023.030887
- By:
- Publication type:
- Article
8
Identification of TNFRSF1A as a novel regulator of carfilzomib resistance in multiple myeloma.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 325, doi. 10.32604/or.2023.030770
- By:
- Publication type:
- Article
9
Combinational therapy with Myc decoy oligodeoxynucleotides encapsulated in nanocarrier and X-irradiation on breast cancer cells.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 309, doi. 10.32604/or.2023.043576
- By:
- Publication type:
- Article
10
Identification and validation of novel prognostic fatty acid metabolic gene signatures in colon adenocarcinoma through systematic approaches.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 297, doi. 10.32604/or.2023.043138
- By:
- Publication type:
- Article
11
NAD+ associated genes as potential biomarkers for predicting the prognosis of gastric cancer.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 283, doi. 10.32604/or.2023.044618
- By:
- Publication type:
- Article
12
Low-molecular-weight fucoidan inhibits the proliferation of melanoma via Bcl-2 phosphorylation and PTEN/AKT pathway.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 273, doi. 10.32604/or.2023.044362
- By:
- Publication type:
- Article
13
CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 261, doi. 10.32604/or.2023.042345
- By:
- Publication type:
- Article
14
High-throughput computational screening and in vitro evaluation identifies 5-(4-oxo-4H-3,1-benzoxazin-2-yl)-2-[3-(4-oxo-4H-3,1-benzoxazin-2-yl) phenyl]-1H-isoindole-1,3(2H)-dione (C3), as a novel EGFR--HER2 dual inhibitor in gastric tumors.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 251, doi. 10.32604/or.2023.043139
- By:
- Publication type:
- Article
15
Circular RNAs in breast cancer diagnosis, treatment and prognosis.
- Published in:
- Oncology Research, 2024, v. 32, n. 2, p. 241, doi. 10.32604/or.2023.046582
- By:
- Publication type:
- Article